Detrimental Effects of Tobacco: Indian Lawyers Sue Government

Regulations by 2FIRSTS.ai
Jan.03.2024
Detrimental Effects of Tobacco: Indian Lawyers Sue Government
Indian lawyers sue government over lack of control on drug and tobacco addiction among youth.

According to an expose by Indian media outlet Mid-day on January 2, two lawyers in Mumbai have filed a lawsuit against the Indian government for its alleged failure to regulate the accessibility of drugs and tobacco, as well as the increasing addiction among young people. The legal notice emphasizes the adverse effects and health hazards of tobacco and highlights the government's inability to control its illegal sale.

 

Lawyers Abid Abbas Sayyed and Saif Alam have issued legal notices to the Chief Minister of Maharashtra, Health Minister, Mumbai Police Commissioner, and the Indian FDA.

 

The notice emphasizes the adverse effects, health hazards, and addictive nature associated with tobacco and highlights the failure to control its illegal sales. Lawyers have urged the government to pay attention to the sale of smuggled cigarettes from abroad and the supply of banned Gutkha (a type of Indian tobacco product).

 

According to survey data, India has approximately 275 million tobacco users, with 35% of the population being 15 years old or older. Of particular concern is the increasing use of tobacco in developing countries, which has contributed significantly to the burden of tobacco-related diseases and premature deaths. The rapid increase in tobacco use among children, adults, and other vulnerable groups in society has raised significant concerns in terms of public health at both local and national levels.

 

Saiyifu stated that the 1975 Cigarettes (Production, Supply and Distribution Regulation) Act mandated the inclusion of statutory health warnings on all cigarette packaging and advertisements. However, the 1975 Cigarettes Act was found to be flawed due to its limited scope and weak provisions. Subsequently, the Cigarettes and Other Tobacco Products Act of 2003 (Prohibition of Advertisement and Regulation of Trade and Commerce, Production, Supply and Distribution) (COTPA) was introduced.

 

Saif said that COTPA is the primary law in India for tobacco control management, providing a more comprehensive approach covering all tobacco products, including cigarettes.

 

The purpose of this law is to safeguard and enhance public health by adopting evidence-based strategies to reduce tobacco consumption. This legislation was approved by India on February 5, 2004, prior to the World Health Organization (WHO) Tobacco Control Framework Convention.

 

In a major move by the government of Maharashtra, as part of the anti-tobacco campaign, the production, sale, and distribution of gutka and tobacco have been prohibited. These items fall under the purview of the Food Safety and Standards Act (FSSA) of 2006.

 

Aram stated that the ban was implemented in July 2012 and the decision was upheld by the Mumbai High Court, receiving further support and extending the ban in Maharashtra until July 2014.

 

Two individuals quoted the 2016-17 Global Adult Tobacco Survey in their notification, emphasizing that a quarter of adolescents in Maharashtra state consume tobacco. Advocate Aram stated, "According to data from the Health and Services Department, from 2016 to March 2022, hospitals and centers in Maharashtra have registered approximately one million patients with a history of tobacco consumption.

 

Alam and Sayeed have requested the police to develop an appropriate action plan through a legal notice and have called on the state government to establish new legislation.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. Fifth Circuit Court Rejects Shenzhen IVPS Appeal: Lack of Abuse Liability Research Key to Loss
U.S. Fifth Circuit Court Rejects Shenzhen IVPS Appeal: Lack of Abuse Liability Research Key to Loss
On July 23, 2025, the U.S. Court of Appeals for the Fifth Circuit ruled to reject the petition for judicial review filed by Shenzhen IVPS Technology Co., Ltd. (IVPS) and its U.S. distributor ECIGRUSA (Worldwide Vape Distribution) against the FDA, thereby upholding the FDA’s denial of their Premarket Tobacco Product Applications (PMTAs) for six open-system e-cigarette devices and components. The court held that the lack of key evidence on “abuse liability” alone was sufficient grounds to support
Aug.15 by 2FIRSTS.ai
E-cigarette shops in Wisconsin, USA, see sales drop due to new regulations
E-cigarette shops in Wisconsin, USA, see sales drop due to new regulations
Wisconsin's new vape regulations have led to a significant drop in sales and stock for vape shops. The law, which bans most vape products, has forced businesses to remove 80% of their stock. Many top sellers are now off-limits, and some customers are traveling out of state to find the products they want. Despite losing a lawsuit against the Department of Revenue, WiscoFAST continues to fight the regulations, arguing that they unfairly target small businesses.
Sep.08
2,500 Smuggled E-Cigarettes Seized in Turkey's Gebze Region, Valued at Approximately $120,000
2,500 Smuggled E-Cigarettes Seized in Turkey's Gebze Region, Valued at Approximately $120,000
In Turkey's Gebze region, 2,500 smuggled e-cigarettes were seized, valued at approximately 5 million Turkish lira (about $120,000), and 4 people were arrested.
Aug.06 by 2FIRSTS.ai
Australian Study: Vaping Three Times More Effective Than Traditional Therapies for Quitting Smoking, Long-Term Health Risks Unclear
Australian Study: Vaping Three Times More Effective Than Traditional Therapies for Quitting Smoking, Long-Term Health Risks Unclear
A new Australian study found flavored nicotine e-cigarettes are three times more effective than gum or lozenges for quitting smoking. The trial of 1,000 smokers on government support showed higher quit rates with vaping, but long-term health risks remain unclear.
Jul.17 by 2FIRSTS.ai
JUUL Labs Statement on FDA Marketing Authorization
JUUL Labs Statement on FDA Marketing Authorization
JUUL Labs said its e-cigarettes have received FDA marketing granted orders (MGOs), meeting the “public health” standard. It noted it is the only major vaping firm not backed by a traditional tobacco company.
Jul.18
Australian Government-Funded Vaping Education Program Featured in The Lancet: Student Vaping Rates Drop by 65%
Australian Government-Funded Vaping Education Program Featured in The Lancet: Student Vaping Rates Drop by 65%
Australia’s “OurFutures” vaping education program cut student vaping rates by 65% after 12 months, according to a trial of 5,000 students across 40 schools. Published in The Lancet, it is the first proven effective school-based e-health intervention in Australia. The program will be expanded through 2028, with long-term data expected in 2026.
Jul.29 by 2FIRSTS.ai